Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on November 29, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print November 29, 2004, doi: 10.1161/01.ATV.0000151648.58516.eb
A more recent version of this article appeared on February 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/2/321    most recent
01.ATV.0000151648.58516.ebv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michaelis, U. R.
Right arrow Articles by Fleming, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michaelis, U. R.
Right arrow Articles by Fleming, I.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CELECOXIB
*PYRROLE

Submitted on June 2, 2004
Accepted on November 12, 2004

Cytochrome P4502C9-Derived Epoxyicosatrienoic Acids Induce the Expression of Cyclooxygenase-2 in Endothelial Cells

U. Ruth Michaelis ; John R. Falck ; Ronald Schmidt ; Rudi Busse ; and Ingrid Fleming *

From the Institut für Kardiovaskuläre Physiologie (U.R.M., R.B., I.F.) and Pharmazentrum Frankfurt, Institut für Klinische Pharmakologie and ZAFES (R.S.), Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany; Department of Biochemistry (J.R.F.), University of Texas Southwestern Medical Center, Dallas, Tex.

* To whom correspondence should be addressed. E-mail: fleming{at}em.uni-frankfurt.de.

Objective-- Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid to epoxyicosatrienoic acids (EETs). CYP2C9-derived EETs elicit endothelial cell proliferation and angiogenesis, but the signaling pathways involved are incompletely understood. Because cyclooxygenase-2 (COX-2) is involved in angiogenesis, we determined whether a link exists between CYP2C9 and COX-2 expression.

Methods and Results-- Human umbilical vein endothelial cells were infected with CYP2C9 sense or antisense adenoviral constructs. Overexpression of CYP2C9 increased COX-2 promoter activity, an effect accompanied by a significant increase in COX-2 protein expression and elevated prostacyclin production. The CYP2C9-induced expression of COX-2 was inhibited by the CYP2C9 inhibitor, sulfaphenazole, whereas 11,12-EET increased COX-2 expression. Overexpression of CYP2C9 and stimulation with 11,12-EET increased intracellular cAMP levels and stimulated DNA-binding of the cAMP-response element-binding protein. The protein kinase A inhibitor, KT5720, attenuated the CYP2C9-induced increase in COX-2 promoter activity and protein expression. Overexpression of CYP2C9 stimulated endothelial tube formation, an effect that was attenuated by the COX-2 inhibitor celecoxib. Identical responses were observed in cells preconditioned by cyclic strain to increase CYP2C expression.

Conclusion-- These data indicate that CYP2C9-derived EETs induce the expression of COX-2 in endothelial cells via a cAMP-dependent pathway and that this mechanism contributes to CYP2C9-induced angiogenesis.


Key words: angiogenesis • endothelium • gene expression • prostacyclin • cytochrome P450




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Webler, R. Popp, T. Korff, U. R. Michaelis, C. Urbich, R. Busse, and I. Fleming
Cytochrome P450 2C9-Induced Angiogenesis Is Dependent on EphB4
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1123 - 1129.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
U. R. Michaelis, N. Xia, E. Barbosa-Sicard, J. R. Falck, and I. Fleming
Role of Cytochrome P450 2C Epoxygenases in Hypoxia-Induced Cell Migration and Angiogenesis in Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. Wray and D. Bishop-Bailey
Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology
Exp Physiol, January 1, 2008; 93(1): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Fleming, A. Rueben, R. Popp, B. Fisslthaler, S. Schrodt, A. Sander, J. Haendeler, J. R. Falck, C. Morisseau, B. D. Hammock, et al.
Epoxyeicosatrienoic Acids Regulate Trp Channel Dependent Ca2+ Signaling and Hyperpolarization in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2612 - 2618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. M. Nusing, H. Schweer, I. Fleming, D. C. Zeldin, and M. Wegmann
Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F288 - F298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Fleming and R. Busse
Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function
Hypertension, April 1, 2006; 47(4): 629 - 633.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Pokreisz, I. Fleming, L. Kiss, E. Barbosa-Sicard, B. Fisslthaler, J. R. Falck, B. D. Hammock, I.-H. Kim, Z. Szelid, P. Vermeersch, et al.
Cytochrome P450 Epoxygenase Gene Function in Hypoxic Pulmonary Vasoconstriction and Pulmonary Vascular Remodeling
Hypertension, April 1, 2006; 47(4): 762 - 770.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
U. R. Michaelis, B. Fisslthaler, E. Barbosa-Sicard, J. R. Falck, I. Fleming, and R. Busse
Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis
J. Cell Sci., December 1, 2005; 118(23): 5489 - 5498.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Vriens, G. Owsianik, B. Fisslthaler, M. Suzuki, A. Janssens, T. Voets, C. Morisseau, B.D. Hammock, I. Fleming, R. Busse, et al.
Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium
Circ. Res., October 28, 2005; 97(9): 908 - 915.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Wang, X. Wei, X. Xiao, R. Hui, J. W. Card, M. A. Carey, D. W. Wang, and D. C. Zeldin
Arachidonic Acid Epoxygenase Metabolites Stimulate Endothelial Cell Growth and Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 522 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pozzi, I. Macias-Perez, T. Abair, S. Wei, Y. Su, R. Zent, J. R. Falck, and J. H. Capdevila
Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids
J. Biol. Chem., July 22, 2005; 280(29): 27138 - 27146.
[Abstract] [Full Text] [PDF]